ATF6B antibody (N-Term)
Quick Overview for ATF6B antibody (N-Term) (ABIN2779487)
Target
See all ATF6B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Sequence
- EIADPTRFFT DNLLSPEDWG LQNSTLYSGL DEVAEEQTQL FRCPEQDVPF
-
Predicted Reactivity
- Cow: 86%, Guinea Pig: 79%, Horse: 93%, Human: 100%, Mouse: 93%, Pig: 86%, Rat: 100%
-
Characteristics
- This is a rabbit polyclonal antibody against CREBL1. It was validated on Western Blot using a cell lysate as a positive control.
-
Purification
- Protein A purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human CREBL1
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 703 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- ATF6B (Activating Transcription Factor 6 beta (ATF6B))
-
Alternative Name
- CREBL1
-
Background
-
CREBL1 bears sequence similarity with the Creb/ATF subfamily of the bZip superfamily of transcription factors. It localizes to both the cytoplasm and the nucleus. The gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6.
Alias Symbols: G13, CREBL1, CREB-RP
Protein Interaction Partner: CREBZF, XBP1, ATF6B, CDK6, UBC, SUMO2, ATF6, NFYC, MBTPS1, PHOX2A, MBTPS2, NFYA, HCVgp1,
Protein Size: 703 -
Molecular Weight
- 77 kDa
-
Gene ID
- 1388
-
NCBI Accession
- NM_004381, NP_004372
-
UniProt
- Q99941
-
Pathways
- Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction
Target
-